ELI LILLY & COMPANY (LLYCL.SN)
Discovers and manufactures prescription medicines for diabetes, cancer, and immune system diseases.
1,129,700.00+0.06%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+50.4%
The outlook
Eli Lilly stock is trading near its 52-week high, well above both its 50- and 200-day moving averages, signaling upward momentum in the recent trend. The trailing P/E of 42.6 reflects a premium valuation. Current market data shows strong technical positioning, though analyst coverage details aren't provided here.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Market cap
$1007.40T
52-wk high
1,134,700.00
52-wk low
608,400.00
50-day avg
1,043,674.50
200-day avg
934,846.60
Trailing P/E
42.6